[
1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
]Search in Google Scholar
[
2. Castro C, Bosetti C, Malvezzi M, et al. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015. Ann Oncol. 2014 Jan;25(1):283-90. doi: 10.1093/annonc/mdt486.
]Open DOISearch in Google Scholar
[
3. Valerianova Z, Atanasov T. (eds.) Cancer Incidence in Bulgaria, 2016 2017. University Specialized Hospital for Active Treatment in Oncology. Bulgarian National Cancer Registry. Paradigma Publ. Sofia, 2020.
]Search in Google Scholar
[
4. Shapiro J, van Lanschot JJB, Hulshof MCCM, et al; CROSS study group. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015 Sep;16(9):1090-1098. doi: 10.1016/S1470-2045(15)00040-6. Epub 2015 Aug 5.
]Open DOISearch in Google Scholar
[
5. Anderson LA, Tavilla A, Brenner H, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5. Eur J Cancer 2015;51:2144-57.
]Search in Google Scholar
[
6. MB Amin, SB Edge, FL Greene, et al. eds. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.
]Search in Google Scholar
[
7. Hsu PK, Chen HS, Liu CC, Wu SC. Application of the Eighth AJCC TNM Staging System in Patients With Esophageal Squamous Cell Carcinoma. Ann Thorac Surg. 2018 May;105(5):1516-1522. doi: 10.1016/j.athoracsur.2017.12.032. Epub 2018 Apr 5.
]Open DOISearch in Google Scholar
[
8. Nicholson AG, Chansky K, Crowley J, et al. Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions; Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016 Mar;11(3):300-11. doi: 10.1016/j.jtho.2015.10.008. Epub 2015 Dec 24.
]Open DOISearch in Google Scholar
[
9. Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. Ann Surg Oncol. 2018 Jul;25(7):1783-1785. doi: 10.1245/s10434-018-6486-6. Epub 2018 Apr 18.
]Open DOISearch in Google Scholar
[
10. Zhang X, Wang Y, Jiang Y, et al. The prognostic impact of tumor length in esophageal cancer: Protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2018 Oct;97(43):e12902. doi: 10.1097/MD.0000000000012902.
]Open DOISearch in Google Scholar
[
11. Zeybek A, Erdoğan A, Gülkesen KH, et al. Significance of tumor length as prognostic factor for esophageal cancer. Int Surg. 2013 Jul-Sep;98(3):234-40. doi: 10.9738/INTSURG-D-13-00075.1.
]Open DOISearch in Google Scholar
[
12. Yendamuri S, Swisher SG, Correa AM, et al. Esophageal tumor length is independently associated with long-term survival. Cancer. 2009 Feb 1;115(3):508-16. doi: 10.1002/cncr.24062. PMID: 19117343.
]Open DOISearch in Google Scholar
[
13. Yang J, Liu Y, Li B, et al. Prognostic significance of tumor length in patients with esophageal cancer undergoing radical resection: A PRISMA-compliant meta-analysis. Medicine (Baltimore). 2019 Apr;98(14):e15029. doi: 10.1097/MD.0000000000015029.
]Open DOISearch in Google Scholar
[
14. Song Z, Wang J, Lin B, Zhang Y. Analysis of the tumor length and other prognosis factors in pT1-2 node-negative esophageal squamous cell carcinoma in a Chinese population. World J Surg Oncol. 2012 Dec 18;10:273. doi: 10.1186/1477-7819-10-273.
]Open DOISearch in Google Scholar
[
15. Wang ZY, Jiang YZ, Xiao W, et al. Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis. BMC Cancer. 2021 Sep 3;21(1):988. doi: 10.1186/s12885-021-08728-1.
]Open DOISearch in Google Scholar
[
16. Yordanov YP, Shef A. Hypertrophic Scars and Keloids – Contemporary Concepts and Treatment Options. Acta Medica Bulgarica 2014; 41(1): 57-74.
]Search in Google Scholar